Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$47.98 - $54.4 $1,151 - $1,305
-24 Reduced 0.61%
3,883 $211 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $189,411 - $226,019
3,907 New
3,907 $200 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Central Valley Advisors, LLC Portfolio

Follow Central Valley Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Valley Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Central Valley Advisors, LLC with notifications on news.